Carriers at higher risk of developing neurodegenerative disease
A team of Canadian scientists, including researchers at the Montreal Neurological Institute and Hospital (The Neuro) has discovered the first French-Canadian founder mutation gene linked to synucleinopathies, a group of neurodegenerative diseases that includes Parkinson鈥檚 disease (PD), dementia with Lewy-Bodies (DLB) and multiple system atrophy (MSA).
Plasticity is enhanced but dysregulated in the aging brain
They say you can鈥檛 teach old dogs new tricks, but new research shows you can teach an old rat new sounds, even if the lesson doesn鈥檛 stick very long.
When it comes to weight gain, the problem may be mostly in our heads, and our genes
Clinicians should consider how the way we think can make us vulnerable to obesity, and how obesity is genetically intertwined with brain structure and mental performance, according to new research.
Scientist Brenda Milner, born in 1918, pioneered memory research
Pioneering neuropsychologist Brenda Milner turns 100 today. Milner made groundbreaking discoveries in the field of human memory. 听
Born on July 15, 1918 in Manchester, UK, Milner came to Canada in 1944 and finished a PhD at 涩里番 under psychologist Donald Hebb in 1952, moving on to a tenured position studying epilepsy patients at the Montreal Neurological Institute and Hospital (The Neuro).
Technique can be used to better categorize patients with neurological disease, according to their therapeutic needs
Personalized medicine 鈥� delivering therapies specially tailored to a patient鈥檚 unique physiology 鈥� has been a goal of researchers and doctors for a long time. New research provides a way of delivering personalized treatments to patients with neurological disease.
Finding is key for future treatment and earlier diagnosis听
Scientists at the Montreal Neurological Institute and Hospital (The Neuro) of 涩里番 have used a unique approach to track brain degeneration in Alzheimer鈥檚 disease, uncovering a pathway through which degeneration spreads from one region to another.
Montreal 鈥� In a study published in Stem Cell Reports, a 涩里番 team of scientists led by Dr.听Carl Ernst, researcher at the Douglas Hospital Research Centre, revealed a molecular mechanism that may play a role in the development of autism.
Endowment to bolster big-data research and help establish Global Brain Consortium at Ludmer Centre
Discovery will aid diagnosis and development of treatments
Scientists at the Montreal Neurological Institute and Hospital (The Neuro) and 涩里番 have identified novel genes associated with a specific form of schizophrenia.
Schizophrenia is a major psychiatric illness affecting one per cent of the population worldwide. Patients suffering from schizophrenia present delusions, hallucinations, abnormal behavior, impairment in daily life and cognitive deficits. Current treatments are insufficient in addressing all of these symptoms.
Award-winning unit will add 10 new beds this year
听
Stroke is the third-leading cause of death in Canada. Each year, some 14,000 Canadians die as a result of a stroke.
June is Stroke Awareness Month, a time to spread awareness of the causes and effects of stroke as well as its treatment.
A look at the latest ALS research and clinical care at The Neuro
Amyotrophic lateral sclerosis (ALS) is a terrible disease with no known cure. Research at The Montreal Neurological Institute and Hospital (The Neuro) is uncovering data that could help find effective treatments for ALS.听
The Neuro鈥檚 Alain Ptito is focussing public attention on the danger of concussion
By Victor Swoboda
On the day that you read this, more than 400 Canadians on average will suffer a concussion or some other brain injury.
Djavad Mowafaghian Foundation shares The Neuro鈥檚 open science vision to accelerate drug discovery and find new and effective treatments for autism spectrum disorders
Today, May 23, 2018, The Montreal Neurological Institute and Hospital (The Neuro) gratefully acknowledged significant government funding and unveiled the Thinking Ahead Campaign (2007-2013) donor wall as a tribute and thank you to the many people who helped transform The Neuro鈥檚 ability to deliver cutting-edge research and clinical care. This ambitious campaign brought people from around the world together to share in one common goal: to accelerate the pace of neuroscience discovery and deliver exceptional care to patients.
CENTECH, a Montreal-based technology incubator, announced earlier that it has selected a company founded by Dr. Etienne de Villers-Sidani for its Propulsion Program, which helps the most innovative start-ups move from the initial development phase to commercializing their products and services on the international market. Dr. de Villers-Sidani is a researcher and neurologist at Montreal Neurological Institute and Hospital (The Neuro) and member of the Center for Research on Brain, Language and Music (CRBLM).
